These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 29076002)

  • 1. Influence of neutrophil-lymphocyte ratio in prognosis of glioblastoma multiforme.
    Lopes M; Carvalho B; Vaz R; Linhares P
    J Neurooncol; 2018 Jan; 136(1):173-180. PubMed ID: 29076002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Cumulative Score Based on Preoperative Neutrophil-Lymphocyte Ratio and Fibrinogen in Predicting Overall Survival of Patients with Glioblastoma Multiforme.
    Hao Y; Li X; Chen H; Huo H; Liu Z; Tian F; Chai E
    World Neurosurg; 2019 Aug; 128():e427-e433. PubMed ID: 31042598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Prognostic Value of the Pretreatment Neutrophil/Lymphocyte Ratio in Patients with Glioblastoma Multiforme Brain Tumors: A Retrospective Cohort Study of Patients Treated with Combined Modality Surgery, Radiation Therapy, and Temozolomide Chemotherapy.
    Brenner A; Friger M; Geffen DB; Kaisman-Elbaz T; Lavrenkov K
    Oncology; 2019; 97(5):255-263. PubMed ID: 31288238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic effect of neutrophil-to-lymphocyte ratio and De Ritis ratio in glioblastoma multiforme patients.
    Uzum Y; Salman T; Oflazoglu U; Yildiz Y; Varol U; Aysin M; Kucukzeybek Y; Alacacioglu A; Tarhan MO
    Bratisl Lek Listy; 2024; 125(8):463-467. PubMed ID: 38989745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutrophil-lymphocyte ratio dynamics during concurrent chemo-radiotherapy for glioblastoma is an independent predictor for overall survival.
    Mason M; Maurice C; McNamara MG; Tieu MT; Lwin Z; Millar BA; Menard C; Laperriere N; Milosevic M; Atenafu EG; Mason W; Chung C
    J Neurooncol; 2017 May; 132(3):463-471. PubMed ID: 28332000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association of pre-treatment neutrophil to lymphocyte ratio with overall survival in patients with glioblastoma multiforme.
    Bambury RM; Teo MY; Power DG; Yusuf A; Murray S; Battley JE; Drake C; O'Dea P; Bermingham N; Keohane C; Grossman SA; Moylan EJ; O'Reilly S
    J Neurooncol; 2013 Aug; 114(1):149-54. PubMed ID: 23780645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pre-operative hematological markers as predictive factors for overall survival and progression free survival in glioblastomas.
    Marini A; Dobran M; Aiudi D; Pesaresi A; di Somma LGM; Iacoangeli M
    Clin Neurol Neurosurg; 2020 Oct; 197():106162. PubMed ID: 32890893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of preoperative hematological markers in patients with glioblastoma multiforme and construction of random survival forest model.
    Duan X; Yang B; Zhao C; Tie B; Cao L; Gao Y
    BMC Cancer; 2023 May; 23(1):432. PubMed ID: 37173662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Effect of Indicators of Systemic Inflammatory Response on Survival in Glioblastoma Multiforme.
    Mermut O; Inanc B
    Turk Neurosurg; 2020; 30(5):658-665. PubMed ID: 32530473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated preoperative neutrophil-to-lymphocyte ratio as a predictor of worse survival after resection in patients with brain metastasis.
    Mitsuya K; Nakasu Y; Kurakane T; Hayashi N; Harada H; Nozaki K
    J Neurosurg; 2017 Aug; 127(2):433-437. PubMed ID: 27911233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relation of baseline neutrophil-to-lymphocyte ratio to survival and toxicity in head and neck cancer patients treated with (chemo-) radiation.
    Bojaxhiu B; Templeton AJ; Elicin O; Shelan M; Zaugg K; Walser M; Giger R; Aebersold DM; Dal Pra A
    Radiat Oncol; 2018 Nov; 13(1):216. PubMed ID: 30400969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab.
    Diem S; Schmid S; Krapf M; Flatz L; Born D; Jochum W; Templeton AJ; Früh M
    Lung Cancer; 2017 Sep; 111():176-181. PubMed ID: 28838390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can Platelet-to-Lymphocyte Ratio (PLR) and Neutrophil-to-Lymphocyte Ratio (NLR) Help Predict Outcomes of Patients With Recurrent Glioblastoma?
    Zemskova O; Yu NY; Leppert J; Löser A; Rades D
    In Vivo; 2024; 38(5):2341-2348. PubMed ID: 39187342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The predictive value of absolute lymphocyte counts on tumor progression and pseudoprogression in patients with glioblastoma.
    Xi J; Hassan B; Katumba RGN; Khaddour K; Govindan A; Luo J; Huang J; Campian JL
    BMC Cancer; 2021 Mar; 21(1):285. PubMed ID: 33726710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative neutrophil-lymphocyte ratio correlated with glioma grading and glioblastoma survival.
    Weng W; Chen X; Gong S; Guo L; Zhang X
    Neurol Res; 2018 Nov; 40(11):917-922. PubMed ID: 30074469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of hypertension on preoperative neutrophil-lymphocyte ratio evaluation of prognosis of renal cell carcinoma.
    Sun J; Ning H; Sun J; Qu X
    Urol Oncol; 2016 May; 34(5):239.e9-15. PubMed ID: 26803433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of preoperative neutrophil to lymphocyte ratio is superior to systemic immune inflammation index for survival in patients with Glioblastoma.
    Lv Y; Zhang S; Liu Z; Tian Y; Liang N; Zhang J
    Clin Neurol Neurosurg; 2019 Jun; 181():24-27. PubMed ID: 30974296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High pretreatment neutrophil-lymphocyte ratio predicts recurrence and poor prognosis for combined small cell lung cancer.
    Shao N; Cai Q
    Clin Transl Oncol; 2015 Oct; 17(10):772-8. PubMed ID: 26243392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of preoperative aspartate aminotransferase to neutrophil ratio index in patients with hepatocellular carcinoma after hepatic resection.
    Ji F; Fu S; Guo Z; Pang H; Chen D; Wang X; Ju W; Wang D; He X; Hua Y; Peng B
    Oncotarget; 2016 Nov; 7(44):72276-72289. PubMed ID: 27472390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutrophil/Lymphocyte Ratio Is an Independent Prognostic Factor in Elderly Patients with High-Grade Gliomas.
    Gan Y; Zhou X; Niu X; Li J; Wang T; Zhang H; Yang Y; Liu Y; Mao Q
    World Neurosurg; 2019 Jul; 127():e261-e267. PubMed ID: 30898756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.